Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Total Voting Rights

5th Jan 2026 15:00

RNS Number : 6833N
GSK PLC
05 January 2026
 

Issued: 5 January 2026, London UK

 

Total Voting Rights

 

 

 

In conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R, GSK plc (the 'Company') hereby notifies the market of the following:

 

The Company's issued share capital as at 31 December 2025 consisted of 4,315,445,026 shares of 31 ¼ pence each ('Ordinary Shares'), of which 240,019,489 Ordinary Shares were held in Treasury.

 

Therefore, the total number of voting rights in the Company is 4,075,425,537. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Notifications may be sent to [email protected].

 

 

V A Whyte

Company Secretary

 

5 January 2026

 

 

About GSK

GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at www.gsk.com.

 

Registered in England & Wales:

No. 3888792

 

Registered Office:

79 New Oxford Street

London

WC1A 1DG

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRBDGDBGXGDGLU

Related Shares:

Glaxosmithkline
FTSE 100 Latest
Value10,124.60
Change79.91